Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3235]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Optimal treatment schedule for pomalidomide in multiple myeloma
Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu...
Optimal treatment schedule for pomalidomide in multiple myeloma ( Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu, Hôpital Huriez, CHRU Lille, France )
19 Dec 2011
Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year
Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben –...
Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year ( Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben – Barts and The London Trust Cancer Centre, UK and Prof Gilles Salles - Universite Claude Bernard Lyon, France )
16 Dec 2011
The changing landscape for NHL treatment
Prof Bertrand Coiffier - Hospices Civils de Lyon, France
The changing landscape for NHL treatment ( Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
16 Dec 2011
Anaemia management update: blood transfusion and ESA use in oncology
Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue...
Anaemia management update: blood transfusion and ESA use in oncology ( Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue and Prof Donat Spahn )
15 Dec 2011
Novel agents and proteasome inhibitors in myeloma
Prof Michele Cavo - University of Bologna, Italy
Novel agents and proteasome inhibitors in myeloma ( Prof Michele Cavo - University of Bologna, Italy )
14 Dec 2011
Advances in peripheral T-cell lymphoma
Prof John Gribben – Barts and The London Trust, London and Prof Bertrand...
Advances in peripheral T-cell lymphoma ( Prof John Gribben – Barts and The London Trust, London and Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
14 Dec 2011
Translational research and proteasome inhibitors in multiple myeloma
Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA
Translational research and proteasome inhibitors in multiple myeloma ( Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2011
Developments in proteasome inhibitors, transplant and myeloma research
Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA
Developments in proteasome inhibitors, transplant and myeloma research ( Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA )
14 Dec 2011
Genomic study of acute myeloid leukaemia
Prof Gail Roboz - Weill Cornell Medical College, New York, USA
Genomic study of acute myeloid leukaemia ( Prof Gail Roboz - Weill Cornell Medical College, New York, USA )
13 Dec 2011
GIMEMA study compares bortezomib-thalidomide-dexamethasone with thalidomide...
Prof Michele Cavo - University of Bologna, Italy
GIMEMA study compares bortezomib-thalidomide-dexamethasone with thalidomide-dexamethasone prior to double autologous stem-cell transplantation ( Prof Michele Cavo - University of Bologna, Italy )
13 Dec 2011
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for...
Prof Antonio Palumbo - University of Torino, Italy
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
13 Dec 2011
History of AORTIC and childhood leukaemia
Dr Chris Williams - University of Washington, Seattle, USA
History of AORTIC and childhood leukaemia ( Dr Chris Williams - University of Washington, Seattle, USA )
12 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation